文献速递心脑血管急症重症综合管理与镇静镇痛

直接胆红素:脑出血后血肿扩大的预测指标

Direct bilirubin: A predictor of hematoma expansion after intracerebral hemorrhage.
PubMed 文献 · Am J Emerg Med · 2023-06-27
一句话结论在急性脑出血患者中,较高的直接胆红素与血肿扩大及3个月不良结局相关,是血肿扩大的预测指标。

该研究回顾性分析2012至2020年连续急性脑出血患者,并在前瞻性验证队列中验证,旨在寻找临床常用实验室指标中与血肿扩大相关的标志物。734例患者中163例(22.2%)出现血肿扩大;直接胆红素每升高1.0 μmol/L,血肿扩大风险增加(校正OR 1.082,95%CI 1.011-1.158),直接胆红素>5.65 μmol/L在验证队列中是血肿扩大的预测指标。较高的直接胆红素还与3个月不良结局相关,中介分析提示该关联部分由血肿扩大中介。作者认为,针对直接胆红素的干预以改善脑出血后预后可能是有意义的,值得进一步探索。

要点

  • 734例急性脑出血患者中163例(22.2%)发生血肿扩大;直接胆红素每升高1.0 μmol/L,血肿扩大的校正OR为1.082(95%CI 1.011-1.158)。
  • 直接胆红素>5.65 μmol/L在验证队列中是血肿扩大的预测指标。
  • 较高的直接胆红素还与3个月不良结局相关,中介分析提示该关联部分由血肿扩大中介。
  • 作者认为,针对直接胆红素的干预以改善脑出血后预后可能是有意义的,值得进一步探索。

适用人群与场景

  • 2012至2020年连续急性脑出血患者,入院时接受实验室检查并有基线和随访CT扫描。

诊断标准与关键阈值

  • 直接胆红素>5.65 μmol/L在验证队列中是血肿扩大的预测指标。

研究设计与关键结果

  • 回顾性分析734例急性脑出血患者,163例(22.2%)出现血肿扩大。
  • 在纳入的实验室指标中,较高的直接胆红素与血肿扩大相关(每1.0 μmol/L变化的校正OR 1.082;95%CI 1.011-1.158)。
  • 直接胆红素>5.65 μmol/L在验证队列中是血肿扩大的预测指标。
  • 较高的直接胆红素还与3个月不良结局相关。
  • 中介分析提示,较高的直接胆红素与不良结局的关联部分由血肿扩大中介。

证据类型、等级与局限

  • 研究类型:回顾性分析连续急性脑出血患者,并在前瞻性验证队列中验证结果。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,直接胆红素的代谢过程及其参与血肿扩大的病理机制可能促成直接胆红素与血肿扩大的关联。
  • 作者认为,针对直接胆红素的干预以改善脑出血后预后可能是有意义的,值得进一步探索。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Previous evidence demonstrated that several biomarkers involved in the pathological process of coagulation/hemostasis dysfunction, impairment of brain vascular integrity and inflammation are associated with hematoma expansion (HE) after intracerebral hemorrhage (ICH). We aimed to explore whether there were unreported laboratory biomarkers associated with HE that were readily and commonly available in clinical practice.

METHODS: We retrospectively analyzed consecutive acute ICH patients from 2012 to 2020 with admission laboratory tests and baseline and follow-up computed tomography (CT) scans. Univariate and multivariate regression analyses were used to evaluate associations between conventional laboratory indicators and HE. The results were verified in a prospective validation cohort. The relationship of candidate biomarker and 3-month outcomes was also investigated and mediation analysis was undertaken to determine causal associations among candidate biomarker, HE and outcome.

RESULTS: Of 734 ICH patients, 163 (22.2%) presented HE. Among the included laboratory indicators, higher direct bilirubin (DBil) was associated with HE (adjusted odds ratio [OR] of per 1.0 μmol/L change 1.082; 95% confidence interval [CI] 1.011-1.158). DBil >5.65 μmol/L was a predictor of HE in validation cohort. Higher DBil was also associated with poor 3-month outcomes. The mediation analysis indicated that the association of higher DBil and poor outcomes was partially mediated by HE.

CONCLUSIONS: DBil is a predictor of HE and poor 3-month outcomes after ICH. DBil's metabolic process and involvement in the pathological mechanism of HE are likely to contribute to the association between DBil and HE. Interventions targeting DBil to improve post-ICH prognosis may be meaningful and worthy of further exploration.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Jia Y, Ye X, Song G, et al. Direct bilirubin: A predictor of hematoma expansion after intracerebral hemorrhage. Am J Emerg Med. 2023. PMID: 37393774. doi:10.1016/j.ajem.2023.06.042

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。